ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections

@article{Kelly2021ACGCG,
  title={ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections},
  author={Colleen R. Kelly and Monika Fischer and Jessica R. Allegretti and Kerry L. LaPlante and David B. Stewart and Berkeley N. Limketkai and Neil H. Stollman},
  journal={The American Journal of Gastroenterology},
  year={2021},
  volume={116},
  pages={1124 - 1147},
  url={https://api.semanticscholar.org/CorpusID:234768271}
}
These guidelines indicate the preferred approach to the management of adults with C. difficile infection and represent the official practice recommendations of the American College of Gastroenterology.
View on Wolters Kluwer
docs.bvsalud.org
402 Citations
Highly Influential Citations
30
Background Citations
73
Methods Citations
10
Results Citations
5

Figures and Tables from this paper

402 Citations

The management of Clostridioides difficile infection: from empirism to evidence

A synthesis of the most recent international guidelines on the management of CDI is presented, including new data on the clinical efficacy of Fidaxomicin (FDX) and Bezlotoxumab and growing literature on fecal microbiota transplantation (FMT).

How Would You Manage This Patient With Clostridioides difficile Infection?

In these rounds, 2 experts, an infectious diseases specialist and a gastroenterologist, discuss antibiotic treatment options for nonsevere disease, the role of fecal microbiota transplantation for fulminant disease, and the use of bezlotoxumab to prevent recurrence in the context of Ms. C, a 48-year-old woman with fulminants C difficile infection.

Current and future approaches in Clostridioides difficile management

New means of management of Clostridioides difficile infection are under development, these including prevention measures (vaccination, population with non-toxigenic strains of the colon, standardized fecal microbiota products) and new antibiotics.

Management of Clostridioides difficile infection: Diagnosis, Treatment, and Future Perspectives.

Controversies in the Prevention and Treatment of Clostridioides difficile Infection in Adults: A Narrative Review

In this narrative review, the authors reviewed available literature regarding the prevention or treatment of CDI in adults and focused on disagreements between the IDSA/SHEA and ACG guidelines, as well as articles that have been published since the updates.

Clostridioides difficile Infection: A Clinical Review of Pathogenesis, Clinical Considerations, and Treatment Strategies

Proper hygiene is indeed noted to be one of the best ways to prevent CDI in the hospital setting and proper prescription of antibiotics can also help reduce the chances of acquiring CDI.

OVERVIEW OF CLINICAL GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CLOSTRIDIODIOIDES DIFFICILE-ASSOCIATED INFECTION

The incidence of community-acquired CD-АI is increasing compared to nosocomial cases and key risk factors include advanced age, antibiotic use, and hospitalization, while preventative measures for recurrence demonstrate promising outcomes.

Advances in the Medical Treatment of Clostridioides difficile Infection.

Current Diagnostic and Treatment Approach of Clostridioides difficile Infection.

The main priority of C. difficile infection  in Indonesia is associated with its prevention, by implementing standard precaution and use of rational antimicrobial.

A Review of Therapies for Clostridioides difficile Infection

A systematic literature review and treatment recommendations based on available evidence for the treatment and prevention of Clostridioides difficile infection are offered.
...

255 References

2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients

An international multidisciplinary panel of experts from the World Society of Emergency Surgery updated its guidelines for management of CDI in surgical patients according to the most recent available literature, including recent changes introduced in the management of this infection.

Recurrent Clostridium difficile infection: From colonization to cure.

Cost-effectiveness of treatment regimens for Clostridioides difficile infection -an evaluation of the 2018 Infectious Diseases Society of America guidelines.

The most effective treatments, with highest cure rates, are also cost-effective due to averted mortality, utility loss, and costs of re-hospitalization and/or further treatments for recurrent CDI.

Practice parameters for the management of Clostridium difficile infection.

This practice parameter will focus on the evaluation, management, and prevention of C difficile infection (CDi), which is increasingly important in the population of patients with colorectal diseases.

European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection.

An update and review on the comparative effectiveness of the currently available treatment modalities of CDI is given, thereby providing evidence-based recommendations on this issue.

Tigecycline for the treatment of patients with Clostridium difficile infection: an update of the clinical evidence

Despite the heterogeneity of the included studies and the small number of patients, the available evidence suggests that tigecycline might be considered as a potential therapeutic option for patients with CDIs, especially in severe cases.

Clostridium difficile Infection in Special High-Risk Populations

An in-depth discussion of CDI in high-risk populations, including the critically ill, oncological patients, solid organ and hematopoietic transplant recipients, patients with inflammatory bowel disease, Patients with kidney disease and pregnant women are presented.

PROBIOTICS FOR THE PREVENTION OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DIARRHEA IN ADULTS AND CHILDREN

Although linked to hospitalization or long-term care facilities, community-acquired C. diff is being diagnosed in people who have fewer comorbidities, use antibiotics less frequenly, are younger, and have fewer healthcare exposures.

Efficacy of oral vancomycin prophylaxis for prevention of Clostridioides difficile infection: a systematic review and meta-analysis

OVP appears to decrease the risk of future CDI in patients with prior CDI who require systemic antimicrobial therapy, however, OVP was not effective for primary prevention of CDI.

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

This guideline updates recommendations regarding epidemiology, diagnosis, treatment, infection prevention, and environmental management on Clostridium difficile infection in adults and includes recommendations for children.
...

Related Papers

Showing 1 through 3 of 0 Related Papers